Innovation in Treatment STIL has pioneered a non-invasive, instant-relief tremor suppression orthosis, addressing an unmet need in the millions affected by Parkinson's and essential tremor, presenting significant market growth potential.

Recent Funding Boost With a recent €2 million capital injection, STIL is poised to expand its production capabilities, accelerate product development, and explore new markets in neurotechnology treatment solutions.

Growth Market Opportunity Operating in a niche with over 30 million affected individuals globally, STIL’s innovative orthosis targets a sizable and underserved segment, creating opportunities for partnerships with healthcare providers and clinics.

Technology Integration Leveraging advanced damping technology within orthotic devices, STIL offers a differentiated product that combines precision engineering with patient-centered relief, appealing to healthcare institutions seeking effective treatment options.

Strategic Collaboration Potential STIL’s focus on neurotechnology and approach to tremor suppression open avenues for collaborations with medical device companies, research institutions, and existing players in neurorehabilitation markets to expand reach and accelerate adoption.